Quest Diagnostics Incorporated (DGX): $9.81 million was the positive money flow into the stock on Monday and the up/down ratio of ticks was also in favor of the bulls at 2.34. The value of trades done on upticks was $17.15 million, whereas, trades done on downticks were valued at $7.34 million. Money flows are calculated as the dollar value of composite uptick trades minus the dollar value of downtick trades. large traders, also sometimes called as the smart money, block traded $9.97 million worth stocks on upticks, which is a bullish indication. The money flow in block trades was $9.97 million. Quest Diagnostics Incorporated (DGX) fell $0.27 traded at $85.79, a change of -0.31% over the previous day. The stock is 0.13% for the week.
Shares of Quest Diagnostics Inc. rose by 0.88% in the last five trading days and 2.86% for the last 4 weeks. Quest Diagnostics Inc. is up 12.11% in the last 3-month period. Year-to-Date the stock performance stands at 22.39%.
Quest Diagnostics Incorporated (NYSE:DGX): The stock opened at $85.81 on Monday but the bulls could not build on the opening and the stock topped out at $86.13 for the day. The stock traded down to $85.62 during the day, due to lack of any buying support eventually closed down at $85.68 with a loss of -0.13% for the day. The stock had closed at $85.79 on the previous day. The total traded volume was 718,121 shares.
In a related news, Britell Jenne K, director of Quest Diagnostics Inc, unloaded 4,000 shares at an average price of $85.2 on August 10, 2016. The total amount of the transaction was worth $340,800, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.